These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20554024)

  • 1. Ion channels in monocytes and microglia/brain macrophages: promising therapeutic targets for neurological diseases.
    Eder C
    J Neuroimmunol; 2010 Jul; 224(1-2):51-5. PubMed ID: 20554024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism.
    Brough D; Le Feuvre RA; Iwakura Y; Rothwell NJ
    Mol Cell Neurosci; 2002 Feb; 19(2):272-80. PubMed ID: 11860279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytes and microglia: responses to neuropathological conditions.
    Singh S; Swarnkar S; Goswami P; Nath C
    Int J Neurosci; 2011 Nov; 121(11):589-97. PubMed ID: 21827229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS.
    Prinz M; Priller J
    J Neuroimmunol; 2010 Jul; 224(1-2):80-4. PubMed ID: 20554025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases.
    Takenouchi T; Sekiyama K; Sekigawa A; Fujita M; Waragai M; Sugama S; Iwamaru Y; Kitani H; Hashimoto M
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):91-6. PubMed ID: 20143170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From bone marrow to microglia: barriers and avenues.
    Davoust N; Vuaillat C; Androdias G; Nataf S
    Trends Immunol; 2008 May; 29(5):227-34. PubMed ID: 18396103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of interleukin-1beta by interleukin-4 in lipopolysaccharide-treated mixed glial cultures: microglial-dependent effects.
    Cao L; Fei L; Chang TT; DeLeo JA
    J Neurochem; 2007 Jul; 102(2):408-19. PubMed ID: 17442043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia and neuroprotection: from in vitro studies to therapeutic applications.
    Polazzi E; Monti B
    Prog Neurobiol; 2010 Nov; 92(3):293-315. PubMed ID: 20609379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury.
    Beschorner R; Nguyen TD; Gözalan F; Pedal I; Mattern R; Schluesener HJ; Meyermann R; Schwab JM
    Acta Neuropathol; 2002 Jun; 103(6):541-9. PubMed ID: 12012085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in ischaemic brain injury: current advances and future perspectives.
    Xia W; Han J; Huang G; Ying W
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):253-8. PubMed ID: 19719754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M; Jonakait GM; Ganea D
    Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.
    Cartier L; Hartley O; Dubois-Dauphin M; Krause KH
    Brain Res Brain Res Rev; 2005 Feb; 48(1):16-42. PubMed ID: 15708626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia.
    Akundi RS; Candelario-Jalil E; Hess S; Hüll M; Lieb K; Gebicke-Haerter PJ; Fiebich BL
    Glia; 2005 Aug; 51(3):199-208. PubMed ID: 15800925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic receptors modulate MAP kinases and transcription factors that control microglial inflammatory gene expression.
    Potucek YD; Crain JM; Watters JJ
    Neurochem Int; 2006 Jul; 49(2):204-14. PubMed ID: 16735081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role.
    Suzuki T; Hide I; Matsubara A; Hama C; Harada K; Miyano K; Andrä M; Matsubayashi H; Sakai N; Kohsaka S; Inoue K; Nakata Y
    J Neurosci Res; 2006 Jun; 83(8):1461-70. PubMed ID: 16652343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of ion channels for macrophage and microglial activation in vitro.
    Brown H; Kozlowski R; Perry H
    Glia; 1998 Jan; 22(1):94-7. PubMed ID: 9436791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
    Walker DG; Lue LF
    J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2Y12 receptor-mediated integrin-beta1 activation regulates microglial process extension induced by ATP.
    Ohsawa K; Irino Y; Sanagi T; Nakamura Y; Suzuki E; Inoue K; Kohsaka S
    Glia; 2010 May; 58(7):790-801. PubMed ID: 20091784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia and inflammation: impact on developmental brain injuries.
    Chew LJ; Takanohashi A; Bell M
    Ment Retard Dev Disabil Res Rev; 2006; 12(2):105-12. PubMed ID: 16807890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain activation of monocyte lineage cells: brain-derived soluble factors differentially regulate BV2 microglia and peripheral macrophage immune functions.
    Shafer LL; McNulty JA; Young MR
    Neuroimmunomodulation; 2002-2003; 10(5):283-94. PubMed ID: 12759565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.